Table 3 Clinical and laboratory findings of BAL with KMT2Ar according to the literature review
Pt | Reference | Age (m) | Gender | Involved organs | WBC (× 109/L) | Hb (g/L) | PLT (× 109/L) |
|---|---|---|---|---|---|---|---|
1 | 13 | 96 | F | Spleen | 43.9 | 80 | 6 |
2 | 14 | 23 | F | Liver, renal, CNS | 87 | 75 | 10 |
3 | 15 | 13 | M | Lymph node, spleen | 60.1 | 83 | 63 |
4 | 15 | 12 | F | Lymph node, spleen, liver | 31.5 | 132 | 261 |
5 | 17 | 11 | F | – | 6.79 | 57 | 57 |
6 | 16 | 4 | M | Skin, testicular | 33.2 | ND | 136 |
7 | 16 | 8 | F | Liver, spleen, adenopathy, skin | 160.9 | ND | 19 |
8 | 18 | 23 | F | Liver, CNS, renal | 87 | 75 | 10 |
9 | 18 | 16 | F | Spleen, CNS | 93.4 | 62 | 133 |
10 | 18 | 5 | M | Renal, skin | 96.5 | 96 | 80 |
11 | 18 | 13 | F | Liver, spleen, lymph node | 24 | 49 | 10 |
12 | 18 | 8 | M | spleen | 14.58 | 64 | 167 |
13 | 19 | 1.5 | F | Liver, spleen | 329 | ND | ND |
14 | 20 | 4 | M | – | 117.2 | 94 | 54 |
15 | 11 | 108 | M | Spleen | 1.8 | 72 | 45 |
16 | 8 | 3 | M | Liver, spleen and renal | 857 | 88 | 46 |
17 | 8 | 6 | M | Liver, spleen and renal, CNS | 119 | 89 | 85 |
18 | 8 | 6 | M | Splenomegaly, skin | 11 | 72 | 104 |
19 | 8 | 13 | F | Lymph node | 39 | 45 | 11 |
20 | 8 | 18 | F | – | 68 | 3 | 16 |
21 | 12 | 15 | F | Liver, renal, lymph node | 54 | 78 | 41 |
22 | 12 | 4 | F | Liver, spleen | 295 | 29 | 45 |
23 | 12 | 48 | F | liver | 209 | ND | 21 |
24 | 9 | 24 | M | liver, spleen, lymph node | 425.58 | 56 | 57 |